Literature DB >> 9234834

Angiotensin converting enzyme gene polymorphism in essential hypertension based on ambulatory blood pressure monitoring.

Y Maeda1, U Ikeda, H Ebata, Y Hojo, Y Seino, H Nakagami, K Shimada.   

Abstract

The association of the angiotensin converting enzyme (ACE) gene polymorphism with essential hypertension is still controversial. We studied its polymorphism in 41 patients with hypertension based on ambulatory blood pressure (ABP) and 34 subjects with normal blood pressure. The ACE genotype was not significantly different between hypertensive and normotensive subjects. Casual blood pressure levels, 24 h, and daytime and nighttime ABP levels did not differ among the ACE genotype in patients with hypertension. In conclusion, the ACE genotype is not associated with essential hypertension based on ABP monitoring.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234834     DOI: 10.1016/s0895-7061(97)00113-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

1.  Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms.

Authors:  H Nakagami; U Ikeda; Y Maeda; K Yamamoto; Y Hojo; K Kario; S Kuroki; K Shimada
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study.

Authors:  Luciana Neves Cosenso-Martin; Renan Oliveira Vaz-de-Melo; Luana Rocco Pereira; Cláudia Bernardi Cesarino; Juan Carlos Yugar-Toledo; José Paulo Cipullo; Marcela Augusta de Souza Pinhel; Dorotéia Rossi Silva Souza; José Fernando Vilela-Martin
Journal:  Eur J Med Res       Date:  2015-09-04       Impact factor: 2.175

3.  Association between angiotensin converting enzyme gene polymorphism and essential hypertension: A systematic review and meta-analysis.

Authors:  Mingyu Liu; Jian Yi; Wenwen Tang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.